Akebia Therapeutics
(AKBA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 169,286 | 245,406 | 115,374 | 147,449 | 122,886 |
| Marketable Securities | N/A | 49,943 | N/A | N/A | 22,727 |
| Receivables | 124,435 | 39,115 | 104,872 | 39,109 | 29,654 |
| Inventories | 88,242 | 104,603 | 111,854 | 116,349 | 115,987 |
| TOTAL | $391,000 | $449,102 | $340,756 | $309,533 | $299,008 |
| Non-Current Assets | |||||
| PPE Net | 8,821 | 9,380 | 9,855 | 10,380 | 12,799 |
| Intangibles | 206,431 | 212,537 | 337,165 | 346,265 | 355,365 |
| Other Non-Current Assets | 69,891 | 74,155 | 99,943 | 105,023 | 128,048 |
| TOTAL | $285,143 | $296,072 | $446,963 | $461,668 | $496,212 |
| Total Assets | $676,143 | $745,174 | $787,719 | $771,201 | $795,220 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 40,403 | 29,413 | 54,379 | 39,217 | 64,362 |
| Accrued Expenses | 123,021 | 142,832 | 124,887 | 129,071 | 126,644 |
| TOTAL | $181,458 | $195,774 | $214,152 | $208,118 | $223,148 |
| Non-Current Liabilities | |||||
| Long Term Debt | 76,608 | 76,338 | 76,072 | 75,805 | N/A |
| Deferred Revenues | 18,034 | 23,529 | 34,886 | 39,830 | 32,142 |
| Other Non-Current Liabilities | 66,455 | 68,260 | 58,332 | 59,401 | 58,871 |
| TOTAL | $176,723 | $179,140 | $177,203 | $168,326 | $104,510 |
| Total Liabilities | $358,181 | $374,914 | $391,355 | $376,444 | $327,658 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 144,539 | 143,317 | 130,266 | 129,858 | 118,943 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -1,090,511 | -1,030,552 | -854,801 | -794,054 | -699,571 |
| Other shareholders' equity | 6 | -9 | 0 | 0 | 6 |
| TOTAL | $317,962 | $370,260 | $396,364 | $394,757 | $467,562 |
| Total Liabilities And Equity | $676,143 | $745,174 | $787,719 | $771,201 | $795,220 |